Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?

about

Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?

Item

http://www.wikidata.org/entity/Q58802466

description

article publié dans la revue scientifique Scientific Reports

@fr

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

наукова стаття, опублікована в серпні 2018

@uk

name

Pre-exposure prophylaxis (PrEP ...... risk individuals be targeted?

@en

type

Item

label

Pre-exposure prophylaxis (PrEP ...... risk individuals be targeted?

@en

prefLabel

Pre-exposure prophylaxis (PrEP ...... risk individuals be targeted?

@en

P1476

Pre-exposure prophylaxis (PrEP ...... risk individuals be targeted?

@en

P2093

Jacky M C Chan

http://www.w3.org/2001/XMLSchema#string

Kai Man Ho

http://www.w3.org/2001/XMLSchema#string

Man Po Lee

http://www.w3.org/2001/XMLSchema#string

Owen T Y Tsang

http://www.w3.org/2001/XMLSchema#string

Shui Shan Lee

http://www.w3.org/2001/XMLSchema#string

Wai Shing Leung

http://www.w3.org/2001/XMLSchema#string

Wilson Lam

http://www.w3.org/2001/XMLSchema#string

Wing Cheong Yam

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Q27009249

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies

Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study

Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men

HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

Who mixes with whom among men who have sex with men? Implications for modelling the HIV epidemic in southern India

A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up

The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

P304

11641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-30101-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ngai Sze Wong

Tsz Ho Kwan

P577

2018-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30076362

http://www.w3.org/2001/XMLSchema#string

P932

6076226

http://www.w3.org/2001/XMLSchema#string